IQVIA Holdings Inc. Share Price & Technical Analysis

IQV · $167.9 (-0.07%)

Healthcare / Diagnostics & Research

AI Score 21 · Bearish

$167.9

-0.07%

IQVIA Holdings Inc. provides clinical research services, commercial insights, and healthcare intelligence to the life sciences and healthcare industries in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment off

Price chart

Seasonality

May has 2 positive and 3 negative years (last 5 years shown)

5% return in May, -4% avg return in past 3 year May month.

-25% return in 2026, 13% avg return in past 3 years.

Swipe sideways to see all months →

JanFebMarAprMayJunJulAugSepOctNovDecYr
262%-22%-2%-8%5%-25%
251%-4%-6%-12%-9%13%18%4%0%14%8%-2%26%
24-9%19%3%-8%-6%-4%16%2%-5%-13%-2%-3%-11%
2310%-9%-4%-5%4%14%0%1%-13%-8%26%8%25%
22-13%-7%0%-6%0%0%11%-11%-14%14%3%-7%-31%

Monthly return % by calendar month · historical pattern, not a forecast

AI snapshotScore 21/100

Bearish · Downtrend · Neutral

IQVIA Holdings Inc. provides clinical research services, commercial insights, and healthcare intelligence to the life sciences and healthcare industries in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment offers a range of cloud-based applications and associated implementation services; real world solutions that enable life sciences and provider customers to generate and disseminate evidence, which informs health care decision making and improves patients' outcomes; and strategic and implementation consulting services, such as advanced analytics and commercial processes outsourcing services. This segment also provides country level performance metrics related to sales of pharmaceutical products, prescribing trends, medical treatment, and promotional activity across various channels, including retail, hospital, and mail order; and measurement of sales or prescribing activity at the regional, zip code, and individual prescriber level. The Research & Development Solutions segment offers project management and clinical monitoring; clinical trial support; strategic planning and design services; and patient and site centric solutions, as well as central laboratory, genomic, bioanalytical, ADME, discovery, vaccine and biomarker laboratory services. The Contract Sales & Medical Solutions segment provides health care provider and patient engagement services, and scientific strategy and medical services. It serves pharmaceutical, biotechnology, device and diagnostic, and consumer health companies. The company was formerly known as Quintiles IMS Holdings, Inc. and changed its name to IQVIA Holdings Inc. in November 2017. IQVIA Holdings Inc. is based in Durham, North Carolina.

Full AI Q&A, portfolio tracking, and live alerts in the app.

Key metrics

Market cap

$29.29B

P/E ratio

21.8

52W high

$247.1

52W low

$136.4

Volume

15,40,791

Beta

1.18

Related stocks in Healthcare

Frequently asked questions

What is IQVIA Holdings Inc. share price today?
IQVIA Holdings Inc. (IQV) last traded around $167.9 on StockPro. Prices refresh every few minutes during market hours.
What technical signals does IQV have?
StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for IQV. Download the app for real-time alerts.
How can I analyze IQVIA Holdings Inc. stock?
Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.

Explore more on StockPro